ProShares UltraShort Silver

ProShares Bitcoin Strategy ETF

Defiance Daily Short Digitizing the Economy ETF

ProShares UltraShort Bloomberg Natrl Gas

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

ARK Innovation ETF

Direxion Daily Semicondct Bull 3X ETF

VS TR -1x Short VIX Futures ETF

GraniteShares 1.25x Long Tesla Daily ETF

Guggenheim Solar ETF

ProShares Ultra Silver

SPDR S&P Regional Banking ETF

ProShares Trust ProShares Short Bitcoin Strategy ETF

MicroSectors Gold Miners 3X Leveraged ETN

iShares Silver Trust

United States Oil Fund

Direxion Daily Semicondct Bear 3X ETF

VS TR 2x Long VIX Futures ETF

ProShares Ultra Bloomberg Natural Gas

Urban Outfitters Inc. Common Stock

Snowflake Inc. Class A Common Stock

AgEagle Aerial Systems Inc. Common Stock

MINISO Group Holding Limited American Depositary Shares each representing four Ordinary Shares

CleanSpark Inc. Common Stock

Aquestive Therapeutics Inc. Common Stock

Marathon Digital Holdings Inc. Common Stock

Dana Incorporated Common Stock

Analog Devices Inc. Common Stock

Riot Platforms Inc. Common Stock

Fastenal Company Common Stock

Edible Garden AG Incorporated Common Stock

SolarEdge Technologies Inc. Common Stock

Enphase Energy Inc. Common Stock

Hims & Hers Health Inc. Class A Common Stock

XPeng Inc. American depositary shares each representing two Class A ordinary shares

Virgin Galactic Holdings Inc. Common Stock

IBO (Listing Market - NYSE Amex Network B F)

New Fortress Energy Inc. Class A Common Stock

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

Click here to get full coverage on We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth - Yahoo Finance

We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth  Yahoo Finance

We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth - Yahoo Finance

Click here to get full coverage on Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025 - GlobeNewswire

Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025  GlobeNewswire

Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025 - GlobeNewswire

Click here to get full coverage on Revolution Medicines Brings Groundbreaking RAS Cancer Research to Major Healthcare Forums - Stock Titan

Revolution Medicines Brings Groundbreaking RAS Cancer Research to Major Healthcare Forums  Stock Titan

Revolution Medicines Brings Groundbreaking RAS Cancer Research to Major Healthcare Forums - Stock Titan

Click here to get full coverage on $RVMD Earnings Results: $RVMD Reports Quarterly Earnings - Nasdaq

$RVMD Earnings Results: $RVMD Reports Quarterly Earnings  Nasdaq

$RVMD Earnings Results: $RVMD Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on Revolution Medicines (NASDAQ:RVMD) Is In A Good Position To Deliver On Growth Plans - simplywall.st

Revolution Medicines (NASDAQ:RVMD) Is In A Good Position To Deliver On Growth Plans  simplywall.st

Revolution Medicines (NASDAQ:RVMD) Is In A Good Position To Deliver On Growth Plans - simplywall.st

Click here to get full coverage on Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday? - Benzinga

Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday?  Benzinga

Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday? - Benzinga

Click here to get full coverage on Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...  Yahoo Finance

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Click here to get full coverage on Revolutionary KRAS Cancer Drug Achieves 61% Response Rate in Lung Cancer Patients - Key Trial Data Released - Stock Titan

Revolutionary KRAS Cancer Drug Achieves 61% Response Rate in Lung Cancer Patients - Key Trial Data Released  Stock Titan

Revolutionary KRAS Cancer Drug Achieves 61% Response Rate in Lung Cancer Patients - Key Trial Data Released - Stock Titan

Click here to get full coverage on New Analyst Forecast: $RVMD Given 'Buy' Rating - Nasdaq

New Analyst Forecast: $RVMD Given 'Buy' Rating  Nasdaq

New Analyst Forecast: $RVMD Given 'Buy' Rating - Nasdaq

Click here to get full coverage on Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting - GlobeNewswire

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting  GlobeNewswire

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting - GlobeNewswire

Click here to get full coverage on Is Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently? - Yahoo Finance

Is Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently?  Yahoo Finance

Is Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently? - Yahoo Finance

Click here to get full coverage on Revolution Medicines Sets Date for Q1 2025 Financial Results: Key Updates Expected from RAS Cancer Pipeline - Stock Titan

Revolution Medicines Sets Date for Q1 2025 Financial Results: Key Updates Expected from RAS Cancer Pipeline  Stock Titan

Revolution Medicines Sets Date for Q1 2025 Financial Results: Key Updates Expected from RAS Cancer Pipeline - Stock Titan

Click here to get full coverage on Revolution Medicines to Participate in April 2025 Investor Conferences - GlobeNewswire

Revolution Medicines to Participate in April 2025 Investor Conferences  GlobeNewswire

Revolution Medicines to Participate in April 2025 Investor Conferences - GlobeNewswire

Click here to get full coverage on Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts  Yahoo Finance

Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Click here to get full coverage on Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress - Stock Titan

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress  Stock Titan

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress - Stock Titan

Click here to get full coverage on Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewswire

Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting  GlobeNewswire

Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewswire

Click here to get full coverage on Revolution Medicines (RVMD): The Best Debt Free Mid Cap Stock to Buy Now - Yahoo Finance

Revolution Medicines (RVMD): The Best Debt Free Mid Cap Stock to Buy Now  Yahoo Finance

Revolution Medicines (RVMD): The Best Debt Free Mid Cap Stock to Buy Now - Yahoo Finance

Click here to get full coverage on Revolutionary Cancer Drug Enters Phase 3 Trial, Targeting 30% of Lung Cancer Patients Without Current Options - Stock Titan

Revolutionary Cancer Drug Enters Phase 3 Trial, Targeting 30% of Lung Cancer Patients Without Current Options  Stock Titan

Revolutionary Cancer Drug Enters Phase 3 Trial, Targeting 30% of Lung Cancer Patients Without Current Options - Stock Titan

Click here to get full coverage on Revolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Revolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...  Yahoo Finance

Revolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Click here to get full coverage on Revolution Medicines, Inc. (RVMD): The Biotech Stock with Biggest Upside Potential - Yahoo Finance

Revolution Medicines, Inc. (RVMD): The Biotech Stock with Biggest Upside Potential  Yahoo Finance

Revolution Medicines, Inc. (RVMD): The Biotech Stock with Biggest Upside Potential - Yahoo Finance

Click here to get full coverage on Revolution Medicines (RVMD) Price Target Reduced by H.C. Wainwri - GuruFocus

Revolution Medicines (RVMD) Price Target Reduced by H.C. Wainwri  GuruFocus

Revolution Medicines (RVMD) Price Target Reduced by H.C. Wainwri - GuruFocus

Click here to get full coverage on Revolution Medicines: Overpriced RAS-Addicted Cancers Maven (NASDAQ:RVMD) - Seeking Alpha

Revolution Medicines: Overpriced RAS-Addicted Cancers Maven (NASDAQ:RVMD)  Seeking Alpha

Revolution Medicines: Overpriced RAS-Addicted Cancers Maven (NASDAQ:RVMD) - Seeking Alpha

Click here to get full coverage on Revolution Medicines (RVMD) Receives Adjusted Price Target from - GuruFocus

Revolution Medicines (RVMD) Receives Adjusted Price Target from  GuruFocus

Revolution Medicines (RVMD) Receives Adjusted Price Target from - GuruFocus

Click here to get full coverage on Revolution Medicines (RVMD) Advances Key Clinical Trials and Strengthens Team | RVMD Stock News - GuruFocus

Revolution Medicines (RVMD) Advances Key Clinical Trials and Strengthens Team | RVMD Stock News  GuruFocus

Revolution Medicines (RVMD) Advances Key Clinical Trials and Strengthens Team | RVMD Stock News - GuruFocus

Click here to get full coverage on When (RVMD) Moves Investors should Listen - news.stocktradersdaily.com

When (RVMD) Moves Investors should Listen  news.stocktradersdaily.com

When (RVMD) Moves Investors should Listen - news.stocktradersdaily.com

Click here to get full coverage on Is Revolution Medicines (RVMD) the Best Mid Cap Biotech Stock to Buy? - Yahoo Finance

Is Revolution Medicines (RVMD) the Best Mid Cap Biotech Stock to Buy?  Yahoo Finance

Is Revolution Medicines (RVMD) the Best Mid Cap Biotech Stock to Buy? - Yahoo Finance

Click here to get full coverage on Revolution Medicines (RVMD) Target Price Raised Amid Positive Ou - GuruFocus

Revolution Medicines (RVMD) Target Price Raised Amid Positive Ou  GuruFocus

Revolution Medicines (RVMD) Target Price Raised Amid Positive Ou - GuruFocus

Click here to get full coverage on Revolution Medicines Secures Massive $750M Public Offering with Upsized Share Sale - Stock Titan

Revolution Medicines Secures Massive $750M Public Offering with Upsized Share Sale  Stock Titan

Revolution Medicines Secures Massive $750M Public Offering with Upsized Share Sale - Stock Titan

Click here to get full coverage on Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewswire

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress  GlobeNewswire

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewswire

Click here to get full coverage on Revolution Medicines to Participate in March 2025 Investor Conferences - GlobeNewswire

Revolution Medicines to Participate in March 2025 Investor Conferences  GlobeNewswire

Revolution Medicines to Participate in March 2025 Investor Conferences - GlobeNewswire

Click here to get full coverage on RVMD Price Target Lowered but Buy Rating Maintained by Guggenheim | RVMD Stock News - GuruFocus

RVMD Price Target Lowered but Buy Rating Maintained by Guggenheim | RVMD Stock News  GuruFocus

RVMD Price Target Lowered but Buy Rating Maintained by Guggenheim | RVMD Stock News - GuruFocus

Click here to get full coverage on Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference  GlobeNewswire

Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Click here to get full coverage on Revolution Medicines (RVMD) Initiates RASolve 301 Phase 3 Trial - GuruFocus

Revolution Medicines (RVMD) Initiates RASolve 301 Phase 3 Trial  GuruFocus

Revolution Medicines (RVMD) Initiates RASolve 301 Phase 3 Trial - GuruFocus

Click here to get full coverage on (RVMD) Investment Report - news.stocktradersdaily.com

(RVMD) Investment Report  news.stocktradersdaily.com

(RVMD) Investment Report - news.stocktradersdaily.com

Click here to get full coverage on Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire

Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference  GlobeNewswire

Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire

Click here to get full coverage on Needham Reiterates Buy Rating for Revolution Medicines (RVMD) | - GuruFocus

Needham Reiterates Buy Rating for Revolution Medicines (RVMD) |  GuruFocus

Needham Reiterates Buy Rating for Revolution Medicines (RVMD) | - GuruFocus

Click here to get full coverage on Groundbreaking Lung Cancer Drug Data Revealed: Revolution Medicines' First Clinical Results - Stock Titan

Groundbreaking Lung Cancer Drug Data Revealed: Revolution Medicines' First Clinical Results  Stock Titan

Groundbreaking Lung Cancer Drug Data Revealed: Revolution Medicines' First Clinical Results - Stock Titan

Click here to get full coverage on Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insig - GuruFocus

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insig  GuruFocus

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insig - GuruFocus

Click here to get full coverage on Revolution Medicines: New Data Underscore A True Cancer Revolution (Upgrade) - Seeking Alpha

Revolution Medicines: New Data Underscore A True Cancer Revolution (Upgrade)  Seeking Alpha

Revolution Medicines: New Data Underscore A True Cancer Revolution (Upgrade) - Seeking Alpha

Click here to get full coverage on Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now - Yahoo Finance

Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now  Yahoo Finance

Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now - Yahoo Finance

Click here to get full coverage on Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewswire

Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares  GlobeNewswire

Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewswire

Click here to get full coverage on Revolution Medicines to Report Financial Results for Fourth - GlobeNewswire

Revolution Medicines to Report Financial Results for Fourth  GlobeNewswire

Revolution Medicines to Report Financial Results for Fourth - GlobeNewswire

Click here to get full coverage on RVMD: Guggenheim Maintains Buy Rating, Lowers Price Target to $8 - GuruFocus

RVMD: Guggenheim Maintains Buy Rating, Lowers Price Target to $8  GuruFocus

RVMD: Guggenheim Maintains Buy Rating, Lowers Price Target to $8 - GuruFocus

Click here to get full coverage on Revolution Medicines, Inc. (RVMD): Among Hedge Funds’ Top Biotech Stock Picks - Yahoo Finance

Revolution Medicines, Inc. (RVMD): Among Hedge Funds’ Top Biotech Stock Picks  Yahoo Finance

Revolution Medicines, Inc. (RVMD): Among Hedge Funds’ Top Biotech Stock Picks - Yahoo Finance

Click here to get full coverage on Oppenheimer Raises Price Target for RVMD, Maintains Outperform Rating | RVMD Stock News - GuruFocus

Oppenheimer Raises Price Target for RVMD, Maintains Outperform Rating | RVMD Stock News  GuruFocus

Oppenheimer Raises Price Target for RVMD, Maintains Outperform Rating | RVMD Stock News - GuruFocus

Click here to get full coverage on Revolution Medicines Announces Pricing of Upsized $750.0 - GlobeNewswire

Revolution Medicines Announces Pricing of Upsized $750.0  GlobeNewswire

Revolution Medicines Announces Pricing of Upsized $750.0 - GlobeNewswire

Click here to get full coverage on Revolution Medicines: Risky Buy On Recent Share Price Dip (NASDAQ:RVMD) - Seeking Alpha

Revolution Medicines: Risky Buy On Recent Share Price Dip (NASDAQ:RVMD)  Seeking Alpha

Revolution Medicines: Risky Buy On Recent Share Price Dip (NASDAQ:RVMD) - Seeking Alpha

Click here to get full coverage on Revolution Medicines Announces Commencement of Public Offering of Common Stock - GlobeNewswire

Revolution Medicines Announces Commencement of Public Offering of Common Stock  GlobeNewswire

Revolution Medicines Announces Commencement of Public Offering of Common Stock - GlobeNewswire

Click here to get full coverage on Revolution Medicines Shares Rise on 'Encouraging' Phase 1 Lung Cancer Trial Data - marketscreener.com

Revolution Medicines Shares Rise on 'Encouraging' Phase 1 Lung Cancer Trial Data  marketscreener.com

Revolution Medicines Shares Rise on 'Encouraging' Phase 1 Lung Cancer Trial Data - marketscreener.com

Click here to get full coverage on Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress - GlobeNewswire

Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress  GlobeNewswire

Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress - GlobeNewswire

Click here to get full coverage on (RVMD) Trading Signals - news.stocktradersdaily.com

(RVMD) Trading Signals  news.stocktradersdaily.com

(RVMD) Trading Signals - news.stocktradersdaily.com

Click here to get full coverage on Revolution Medicines Q1 2025 Earnings Call Transcript - MarketBeat

Revolution Medicines Q1 2025 Earnings Call Transcript  MarketBeat

Revolution Medicines Q1 2025 Earnings Call Transcript - MarketBeat

Click here to get full coverage on Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...  Yahoo

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo

Click here to get full coverage on Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround - Yahoo Finance

Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround  Yahoo Finance

Revolution Medicines Inc (RVMD)

Price Chart

Key Statistics

Technicals

About RVMD

Latest News

We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth - Yahoo Finance

Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025 - GlobeNewswire

Revolution Medicines Brings Groundbreaking RAS Cancer Research to Major Healthcare Forums - Stock Titan

Advanced Charts

Top Gainers

Top Losers